Original Articles 172
Megaloblastic anaemia: Prevalence and causative factors
Uma Khanduri, Archna Sharma
ABSTRACT
Background. Megaloblastic anaemia is not uncommon
in India, but data are insufficient regarding its prevalence,
and causative and precipitating factors. We did a prospective
study to document such data for patients of megaloblastic
anaemia.
Methods. All patients presenting to our hospital
over a period of 6 months with a haemoglobin <10 g/dl and/or
mean corpuscular volume >95 fL and blood film findings
consistent with megaloblastosis were included in the study.
Demographic data, diet, drug intake, previous blood
transfusion and presenting symptoms were recorded. Clinical
findings were obtained from medical records of patients.
Complete blood counts, blood film examination, reticulocyte
count and cobalamin and folate assays were done. Results of
liver function tests and bone marrow slides were available for
review.
Results. Megaloblastic anaemia was diagnosed
in 175 patients with anaemia. Assays were done on 120 patients
(55 were lost to follow up) and results showed cobalamin
deficiency in 78 patients (65%), combined cobalamin and folate
deficiency in 20 patients (12%) and pure folate deficiency in
8 patients (6%). Fifteen per cent of patients had normal or
high values of both vitamins, having received blood or
haematinics before the diagnosis was established. The peak
incidence of megaloblastic anaemia was in the age group of
10–30 years (48%), with female preponderance (71%). The
predominant symptoms were fatigue, anorexia and gastritis, low
grade fever, shortness of breath, palpitations and mild
jaundice. Twenty-five per cent of patients were on
acid-suppressing medication and 15% had previous transfusion
for anaemia. Eighty-seven per cent of patients with cobalamin
deficiency and 75% with folate deficiency were
lactovegetarians. In the combined deficiency cohort, 71% were
vegetarians and 29% were occasional non-vegetarians. Physical
findings were pallor (85%), glossitis (29%), mild icterus
(25%) and hyperpigmentation (18%).
Abnormal haematological findings were mean corpuscular
volume 77–123 fL (9 patients had iron deficiency), red cell
distribution width 16%–44%, pancytopenia in 62% of patients,
reticulocyte count >2% in 42% of patients and typical
megaloblastic blood films in all patients. Bone marrow smears
available in 22 patients showed moderate-to-severe
megaloblastosis. Thirty-two per cent of patients in whom liver
function tests were done showed indirect bilirubinaemia with
normal enzymes.
Conclusion. Megaloblastic anaemia was diagnosed
from complete blood counts, red cell indices, blood film
examination and assays of the two vitamins.
Bone marrow examination was not essential for diagnosis.
Cobalamin deficiency was the major cause of megaloblastosis.
Aetiological factors were a diet poor in cobalamin or folate,
increased requirements during the growth period and pregnancy,
and the use of acid-suppressing medication. Physicians
managing these patients need to be aware of the timing of
blood sampling for assays, that haematinics and transfusions
provide only short term benefits, and that long term follow up
and diet counselling is crucial.
Natl Med J India 2007;20:172
ê5
INTRODUCTION
Megaloblastic anaemia has been recognized as a clinical entity
for over a century. The first clinical description of
pernicious anaemia, which is one of the known causes of
megaloblastic anaemia, has been attributed to Thomas Addison
in 1849.1
Much of the early work on megaloblastic/pernicious anaemia was
done on western subjects. Megaloblastic anaemia results from
abnormal maturation of haematopoietic cells due to faulty DNA
synthesis. Two vitamins, cobalamin (vitamin B12)
and folic acid are essential for DNA
biosynthesis. Deficiency of either vitamin results in
asynchrony in the maturation of the nucleus and cytoplasm of
rapidly regenerating cells. In the haematopoietic system this
asynchrony results in abnormal nuclear maturation with normal
cytoplasmic maturation, apoptosis, ineffective erythropoiesis,
intramedullary haemolysis, pancytopenia and typical
morphological abnormalities in the blood and marrow cells.2,3
Megaloblastic anaemia leads to substantial morbidity if
unrecognized or misdiagnosed. Its aetiology is multifactorial
and may result from dietary deficiency, impaired absorption
and transport or impaired utilization of these vitamins in DNA
synthesis. In India with diverse ethnic populations, different
dietary and social customs, the incidence of megaloblastic
anaemia and its associated problems have not been adequately
documented.
Severe megaloblastic anaemia is not uncommon among patients
who present with symptomatic anaemia in hospitals around
Delhi. We did a prospective study between April and September
2003 at St Stephen’s Hospital, Delhi to document the incidence
of megaloblastic anaemia in our hospital, determine which of
the two vitamins was responsible, document the clinical
presentation and dietary practices in affected patients, and
identify any precipitating factors.
METHODS
The inclusion criteria for the study were a haemoglobin level
<10 g/dl and/or a mean corpuscular volume (MCV) >95 fL along
with peripheral blood film findings consistent with
megaloblastosis (pancytopenia, anisopoikilocytosis,
macrocytosis, tear drop cells, hypersegmented neutrophils,
macropolycytes and presence of basophilic stippling,
Howell–Jolly bodies or nucleated red cells with megaloblastic
change).
A proforma was used to document demographic data, clinical
presentation, dietary history, past history of anaemia, blood
transfusions and drugs. Details of physical examination were
obtained from medical records of patients. With informed
consent, two blood samples were collected from each patient, 2
ml in EDTA for complete blood counts (CBC) and 5 ml clotted
blood for serum. CBC were done on the day of blood sampling.
Serum was separated from clotted blood and stored frozen at
–25 °C until assayed in batches for cobalamin and folate
levels. The laboratory tests performed were:
-
CBC using the Ac.T(diff)
cell counter from Beckman Coulter.
-
A blood film was stained by the Leishman
stain4 and evaluated for red cell
morphology, platelet count and white cell morphology by 2
haematologists. A differential count of 100 neutrophils
based on the number of lobes (from 1 to >6) was done on all
available blood films.
-
Reticulocyte count using 1% Brilliant
Cresyl Blue for supravital staining.5
-
Serum folate and cobalamin levels were
done on patients who were admitted to hospital and on those
who attended the follow up clinic. The vitamins were assayed
using competitive enzyme immunoassay on Immunoassay Analyser
AIA-600 (TOSOH, Japan). For both assays, the instrument was
calibrated using 5 commercial calibrators and high and low
controls were run in each batch that was analysed. The
normal range of cobalamin using the AIA PACK B12 was 100–700
pg/ml and folate using AIA PACK FOLATE was 3.0–22 ng/ml.
-
Liver function tests were requested by
attending physicians in patients who were clinically
jaundiced. These were done using the HITACHI 911
Autoanalyzer (Roche, Germany).
-
Bone marrow examination was requested by
attending physicians in some patients. The slides were
stained by the May Grunwald Giemsa stain.4
RESULTS
During the study, 26 630 blood samples were received for CBC
in the laboratory. Of these 6412 samples (24%) had a
haemoglobin value <10 g/dl. The number of patients who met the
inclusion criteria was 175 (2.7% of patients with anaemia). Of
these, 120 cases were available for review and assays as 55
patients did not come for follow up.
Based on the analysis, the patients were divided into 4
groups (Table I).
Group A: Hb <10 g/dl, MCV >95 fL,
megaloblastic blood film, low cobalamin and/or folate
levels.
Group B: Hb <10 g/dl, MCV >95 fL, megaloblastic blood film,
normal or high cobalamin and/or folate (partially treated or
transfused patients).
Group C: Hb or MCV in the normal range, megaloblastic blood
film and low cobalamin and/or folate levels.
Group D: Hb <10 g/dl, MCV >95 fL, megaloblastic blood film
and no assays available.
Of the 120 patients (50 men, 70 women;
age range: 9 months to 80 years; Fig. 1) who had assays done
for cobalamin and folate, 78 (65%) had cobalamin deficiency, 8
(6%) had folate deficiency and 14 (12%) had combined
deficiency. Twenty patients (17%) had normal or high values of
both vitamins, having received treatment before sampling for
assays.
Table I. Distribution of patients in the four groups
|
Deficiency |
Groups
|
Total |
| A |
B |
C |
D |
| Cobalamin |
46 |
- |
32 |
- |
78 |
| Folate |
6 |
- |
2 |
- |
8 |
| Combined |
11 |
- |
3 |
- |
14 |
| Unknown |
- |
20 |
- |
55 |
75 |
| Total |
63 |
20 |
37 |
55 |
175 |
Group A: Haemoglobin (Hb) <10 g/dl, mean corpuscular volume
(MCV) >95 fL, low cobalamin and/or folate
Group B: Hb <10 g/dl, MCV >95 fL, normal or high cobalamin
and/or folate
Group C: Hb or MCV normal, low cobalamin and/or folate
Group D: Hb <10 g/dl, MCV >95 fL, no assays available
Three patients were pregnant at the time
of investigation and all of them had cobalamin deficiency. Two
girls <1 year of age with severe anaemia had cobalamin
deficiency. The nutritional status of their mothers was not
known. All patients were residents of Delhi and its suburbs
within a radius of 25 km from central Delhi. Eighty-seven per
cent of patients with cobalamin deficiency and 75% of patients
with folate deficiency were lactovegetarians. In the combined
deficiency cohort, 71% were lactovegetarians. Even
non-vegetarian patients ate meat only occasionally. All
patients were from the middle and low income groups. A history
of intake of H2 receptor blockers or
proton pump inhibitors namely ranitidine and omeprazole was
obtained in 30 patients. These drugs had been prescribed or
bought over-the-counter for symptomatic relief of gastritis
and anorexia.
The predominant symptoms were fatigue (70%), anorexia and
gastritis (60%), low grade fever (50%), cardiovascular
(shortness of breath, palpitations and syncope) (30%) and
yellow discoloration of eyes (20%). Paraesthesias, diarrhoea,
hyperpigmentation and early graying of hair were present in
<10% of patients. The duration of symptoms ranged from a few
days to 3 years. Eighteen patients (15%) had received blood
transfusions for anaemia, 1–3 years before the present
hospital visit.
The physical signs recorded by the attending physicians
included pallor (85%), glossitis (29%), mild icterus (25%) and
hyper-pigmentation of knuckles (18%). A detailed neurological
evaluation was not recorded.
The main haematological findings are shown in Table II. The
MCV ranged from 77 fL to 123 fL. Nine patients whose MCVs were
<95 fL and belonged to Group C were also iron-deficient. The
red cell distribution width (RDW), which is an indicator of
the variation in the size of red cells, ranged from 16% to 44%
(normal: up to 13.5%).
Pancytopenia was present in 74 patients (62%). Reticulocyte
count was done in 74 patients and was found to be >2% in 42%.

FIG 1. Age and sex
distribution of patients
Blood films showed marked
anisopoikilocytosis, both microcytic and macrocytic red cells,
substantial number of tear drop cells, leukopenia and
thrombocytopenia. Nucleated red cells with megaloblastic
nuclei and red cell inclusions such as Cabot rings, basophilic
stippling and multiple Howell–Jolly bodies were seen (Fig. 2).
Hypersegmentation of neutrophils (>5 lobes) was present in
all blood films examined and ranged from 2% to 60% of
neutrophils. Bone marrow examination was done in 22 patients.
Marrow smears were moderate to markedly hypercellular with
moderate-to-severe megaloblastic change in all haematopoietic
precursor cells.
Liver function tests were done in 62 patients; of these 20
patients (32.2%) had raised indirect bilirubin levels with
normal liver enzymes. Serum lactate dehydrogenase was
requested for in only 4 patients and the levels were increased
in all of them.
DISCUSSION
Based on the western literature there is a perception that
folate deficiency is the main cause of megaloblastic anaemia.
Only 2.7% of patients with anaemia in our hospital had
megaloblastic anaemia. Cobalamin deficiency was responsible
for megaloblastic anaemia in the majority of our patients (65%
pure cobalamin deficiency and 12% combined deficiency) and
pure folate deficiency

FIG 2. Peripheral blood film ( ´1000)
showing paucity of red cells, marked anisopoikilocytosis, tear
drop cells. Macrocytes were recognized by comparing the size
of red blood cells with that of mature small lymphocytes (L).
Platelets were reduced in number. Basophilic stippling was
seen (arrow).
Table
II. Haematological data
|
Laboratory parameter |
Deficiency |
| |
Cobalamin (n=78) |
Folate (n=8) |
Combined (n=14) |
Unknown (n=20) |
|
Haemoglobin (g/dl) |
|
|
|
|
|
1.5–5.0 |
27 |
2 |
7 |
10 |
|
5.1–10 |
41* |
6 |
7 |
10 |
|
Mean (SD) MCV (fL) |
106(16) |
103.9(12.5) |
106(14.9) |
110.9(10.7) |
|
Mean (SD) RDW (%) |
23.6 (7.2) |
22 (2.67) |
26(6.6) |
24.7(4.6) |
|
White cell count
<4.5´109/L |
62.8% |
62.5% |
85.7% |
45% |
|
Platelet count <150´109/L |
67.9% |
62.5% |
71.4% |
80% |
|
Reticulocyte count >2% |
39.1% |
33.3% |
50% |
50% |
* 10 patients had haemoglobin (Hb) >10
g/dl with mean corpuscular volume (MCV) >95 fL (Hb normal
range 11.5–18 g/dl and MCV normal range 82–92 fL) RDW Red
cell distribution width (normal 11.5%–13.5%)
White cell count normal range 4.5–10.5x109/L
accounted for 6%. We were unable to
determine which vitamin was deficient in 17% as the patients
had received haematinics and blood transfusions before
sampling for the assays could be done.
Megaloblastic anaemia is a chronic condition developing
over a period of time and most patients are well compensated.
There is no indication for urgent blood transfusion. Serum
samples for assay of the 2 vitamins should be drawn before any
form of therapy is given since assays alone can determine
which vitamin is deficient.
The majority of our patients were lactovegetarians. The
average Indian vegetarian diet is deficient in cobalamin.7,8
An earlier pilot study reported by us had shown that 40% of
normal Indian subjects with normal haemograms were
cobalamin-deficient.6
A 1973 study by WHO on the nutritional status of pregnant
women in India documented iron, folate and cobalamin
deficiency.9In
obstetric practice supplementation of iron and folate is the
norm. Folate supplementation alone in the presence of occult
cobalamin deficiency may precipitate neurological
complications.2,10
We attempted to identify factors that might be responsible
for converting occult cobalamin deficiency into florid
megaloblastic anaemia. In Caucasian and Chinese populations,
megaloblastic anaemia is reported to occur in older age groups
with an equal sex ratio or male preponderance.11,12
In contrast, the peak incidence in our
study was seen in the age group of 10–30 years (48% of
patients) and there was a preponderance of women (71%). It is
possible that the increased demand during growth spurt,
puberty and child-bearing age group in a population already
deficient in cobalamin precipitated the anaemia.
Gastritis, anorexia, nausea and vomiting were present in
60% of patients. The lining epithelium of the gastrointestinal
tract becomes atrophic in megaloblastosis. A vicious cycle of
megaloblastosis leading to atrophy of mucosa, and subsequent
malabsorption of the two vitamins, worsens megaloblastic
anaemia.
A history of intake of acid-suppressing medication (H 2
receptor antagonists and proton pump inhibitors) was present
in 25% of our patients. These drugs had been prescribed for
gastritis by their primary physicians and were often purchased
from pharmacies over-the-counter without prescriptions. These
drugs may play a role in malabsorption of cobalamin.13,14
Strict regulation in prescribing and dispensing these
medications should be considered. We did not document
malabsorption in these patients.
For a laboratory diagnosis of megaloblastic anaemia, a CBC
with red cell indices, examination of a well stained blood
film and assay of the 2 vitamins are sufficient to make a
definitive diagnosis. Pancytopenia was present in 62% of
patients. Other authors have also observed that megaloblastic
anaemia must be an important differential diagnosis in
patients presenting with pancytopenia.15,16
Bone marrow examination does not contribute to the diagnosis
of the underlying aetiology and should be done when a
diagnosis of myelodysplasia is being considered.
Liver function tests showed a mild indirect
hyperbilirubinaemia with normal enzymes in 32% of the patients
tested. Estimation of serum methyl malonic acid and
homocysteine, which are better indicators of cobalamin and
folate deficiency at the tissue level,17,19
were not done due to cost constraints.
In conclusion, megaloblastic anaemia causes substantial
morbidity in patients with anaemia. Data regarding the
magnitude of the problem in different parts of India and the
factors that might influence its incidence are lacking.
Megaloblastic anaemia must be considered in the differential
diagnosis of patients presenting with pyrexia of unknown
origin, mild icterus or pancytopenia. Documentation of occult
cobalamin deficiency in different ethnic and socioeconomic
groups and in pregnant women needs to be done. The effect on
neonates of cobalamin-deficient mothers should also be
studied.
A large volume of recent literature links serum levels of
homocysteine and methyl malonic acid in cobalamin and folate
deficiency to occlusive cardiovascular disease and
neurological manifestations.20-23
Complete evaluation for subtle neurological signs and cardiac
function needs to be done in the at-risk population to assess
the deficiency of these vitamins.
Patients are being treated in the short term with
haematinics and transfusions with relief of symptoms. In most
instances long term follow up and diet counselling are not
being done. The fortification of diet to prevent
megaloblastosis needs to be taken up as a national public
health issue.
ACKNOWLEDGEMENTS
We acknowledge the cooperation of the
Departments of Medicine, Surgery, Paediatrics and Obstetrics
and Gynaecology for referring patients for the study.
REFERENCES
-
Addison T. Anaemia—disease of the
suprarenal capsules. London Med Gazette 1849;43:517–18.
-
Antony AC. Megaloblastic anemia. In:
Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ,
Silberstein LE, et al. (eds). Hematology. Basic
principles and practice. 4th ed. Edinburgh:Churchill
Livingstone; 2005:519–56.
- Carmel R. Megaloblastic anemias: Disorders of impaired
DNA synthesis. In: Greer JP, Foerster J, Lukens JN, Rodgers
GM, Paraskevas F, Glader B (eds). Wintrobe’s clinical
hematology. 11th ed. Philadelphia:Lippincott Williams
and Wilkins; 2004:1367–95.
-
Bain BJ, Lewis SM. Preparation and
staining methods for blood and bone marrow films. In: Lewis
SM, Bain BJ, Bates I (eds). Practical haematology by
Dacie and Lewis. 9th ed. Edinburgh:Churchill
Livingstone; 2001:47–64.
-
Bain BJ, Bates I. Basic haematological
techniques. In: Lewis SM, Bain BJ,
Bates I (eds). Dacie and Lewis Practical haematology.
9th ed. Edinburgh:Churchill Livingstone; 2001:19–46.
-
Khanduri U, Sharma A, Joshi A. Occult
cobalamin and folate deficiency in Indians. Natl Med J
India 2005;18:182–3.
-
Antony AC. Vegetarianism and vitamin
B-12 (cobalamin) deficiency. Am J Clin Nutr 2003;78:3–6.
-
Antony AC. Prevalence of cobalamin
(vitamin B12) and folate deficiency in India—audi altera
partem. Am J Clin Nutr 2001;74:157–9.
-
Yusufji D, Mathan VI, Baker SJ. Iron,
folate and vitamin B12 nutrition in pregnancy: A study of
1000 women from southern India. Bull World Health Organ
1973;48:15–22.
-
Refsum H. Folate, vitamin B12 and
homocysteine in relation to birth defects and pregnancy
outcome. Br J Nutr 2001;85 (Suppl 2):109–13.
-
Chan JCW, Liu HSY, Kho BCS, Chu RW, Ma
ESK, Ma KM, et al.
Megaloblastic anaemia in Chinese patients: A review of 52
cases. Hong Kong
Med J 1998;4:269–74.
-
Clarke R, Grimley Evans J, Schneede J,
Nexo E, Bates C, Fletcher A, et al. Vitamin B12 and
folate deficiency in later life. Age Ageing 2004;33:34–41.
-
Marcuard SP, Albernaz I, Khazanie PG.
Omeprazole therapy causes malabsorption of cyanocobalamin
(vitamin B12). Ann Intern Med 1994;120:211–15.
-
Schenk BE, Kuipers EJ,
Klinkenberg-Knol EC, Bloemena EC, Sandell M, Nelis GF, et
al. Atrophic gastritis during long-term omeprazole
therapy affects serum vitamin B12 levels. Aliment
Pharmacol Ther1999;13:1343–6.
-
Sarode R, Garewal G, Marwaha N,
Marwaha RK, Varma S, Ghosh K, et al.
Pancytopenia in nutritional megaloblastic anaemia. A study
from north-west India. Trop Geogr Med 1989;41:331–6.
-
Kumar R, Kalra SP, Kumar H, Anand AC,
Madan N. Pancytopenia—a six year study. J Assoc
Physicians India 2001;49:1078–81.
-
Allen RH, Stabler SP, Savage DG,
Lindenbaum J. Diagnosis of cobalamin deficiency. I.
Usefulness of serum methylmalonic acid and total
homocysteine concentrations. Am J Hematol 1990;34:90–8.
-
Refsum H, Yajnik CS, Gadkari M,
Schneede J, Vollset SE, Örning L, et al.
Hyperhomocysteinemia and elevated methylmalonic acid
indicate a high prevalence of cobalamin deficiency in Asian
Indians. Am J Clin Nutr 2001;74:233–41.
-
Carmel R, Mallidi PV, Vinarskiy S,
Brar S, Frouhar Z. Hyperhomocysteinemia and cobalamin
deficiency in young Asian Indians in the United States.
Am J Hematol 2002;70:107–14.
-
Giles WH, Croft JB, Greenlund KJ, Ford
ES, Kittner SJ. Association between total homocysteine and
the likelihood for a history of acute myocardial infarction
by race and ethnicity: Results from the Third National
Health and Nutrition Examination Survey. Am Heart J
2000;139:446–53.
-
Chambers JC, Kooner JS. Homocysteine:
A novel risk factor for coronary heart disease in UK Indian.
Asians Heart 2001;86:121–2.
-
Carmel R, Gott PS, Waters CH, Cairo K,
Green R, Bondareff W, et al. The frequently low
cobalamin levels in dementia usually signify treatable
metabolic, neurologic and electrophysiologic abnormalties.
Eur J Haematol 1995;54:245–53.
-
Karnaze DS, Carmel R. Neurologic and
evoked potential abnormalities in subtle cobalamin
deficiency states, including deficiency without anaemia and
with normal absorption of free cobalamin. Arch Neurol
1990;47:1008–12.
|